JENNIFER MOSTELLER: Open Payments
NPI 1801356530 · LOGAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$455 in 23 payments from 13 companies in 2025. Trend: 2023 $392 · 2024 $400 · 2025 $455
Food & beverage: $455
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $145 |
| Exeltis, USA Inc. | 1 | $67 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $36 |
| Lilly USA, LLC | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Exact Sciences Corporation | 1 | $20 |
| Boston Scientific Corporation | 1 | $20 |
| Acella Pharmaceuticals, LLC | 1 | $20 |
| Organon LLC | 1 | $17 |
Products named: TWIRLA, VRAYLAR, QULIPTA, UBRELVY, JOURNAVX, MOUNJARO, Auvelity, CAPLYTA.
Industry payments across UT — which companies pay providers there.
